project id: TCGA-KIRC; case submitter id: TCGA-B2-A4SR; analyte type: DNA; selected normal wgs: true; selected normal wxs: true; source center: 23; state: released; a260 a280 ratio: 1.66; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.66; rna integrity number: 9.5; age at index: 61; days to birth: -22637; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1951; age at diagnosis: 22637; ajcc clinical m: M0; ajcc pathologic m: M0; ajcc pathologic n: NX; ajcc pathologic stage: Stage II; ajcc pathologic t: T2a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 507.0; icd 10 code: C64.9; last known disease status: not reported; morphology: 8310/3; primary diagnosis: Clear cell adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Kidney, NOS; synchronous malignancy: No; tissue or organ of origin: Kidney, NOS; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; cigarettes per day: 2.5205479452054793; pack years smoked: 46.0; years smoked: 46.0; is ffpe: false; composition: Not Reported; days to collection: 243; days to sample procurement: 0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0;